Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > EBITDA Margin

Amneal Pharmaceuticals Inc EBITDA Margin Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly EBITDA Margin from 2016 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amneal Pharmaceuticals Inc EBITDA Margin for the quarter ending December 12, 2018 was $22m a -41.75% decrease of -9m year over year
  • Amneal Pharmaceuticals Inc EBITDA Margin for the last 12 months ending December 12, 2018 was $25m a -21.56% decrease of -5m year over year
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2018 was $25m a -14.83% decrease of -4m from 2017
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2017 was $29m a -5.67% decrease of -2m from 2016
  • Amneal Pharmaceuticals Inc Annual EBITDA Margin for 2016 was $30m a 3.18% increase of 1m from 2015
Other Margins & Efficiency Metrics:
  • Amneal Pharmaceuticals Inc Return on Capital % for the quarter ending December 12, 2018 was 4.18 a -281.33% decrease of -11.75 year over year
  • Amneal Pharmaceuticals Inc Return on Equity % for the quarter ending December 12, 2018 was -8.98
View Chart On Koyfin

Quarterly AMRX EBITDA Margin Data

12/2018$22m
09/2018$29m
06/2018$25m
03/2018$31m
12/2017$32m
09/2017$28m
06/2017$21m
03/2017$24m
12/2016$34m

Annual AMRX EBITDA Margin Data

2018$25m
2017$29m
2016$30m
2015$29m
2014$31m